首页> 美国卫生研究院文献>other >Design Synthesis Antiviral Activity and Pre-formulation Development of Poly-L-Arginine-Fatty acyl Derivatives of Nucleoside Reverse Transcriptase Inhibitors
【2h】

Design Synthesis Antiviral Activity and Pre-formulation Development of Poly-L-Arginine-Fatty acyl Derivatives of Nucleoside Reverse Transcriptase Inhibitors

机译:核苷类逆转录酶抑制剂的聚-L-精氨酸-脂肪酰基衍生物的设计合成抗病毒活性和预配制开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The objective of this work was to design conjugates of anti-HIV nucleosides conjugated with fatty acids and cell penetrating poly-L-arginine (polyArg) peptides. Three conjugates of polyArg cell-penetrating peptides with fatty acyl derivatives of alovudine (FLT), lamivudine (3TC), and emtricitabine (FTC) were synthesized. In general, the compounds exhibited anti-HIV activity against X4 and R5 cell-free virus with EC50 values of 1.5–16.6 μM. FLT-CO-(CH2)12-CO-(Arg)7 exhibited EC50 values of 2.9 μM and 3.1 μM against X4 and R5 cell-free virus, respectively. The FLT conjugate was selected for further preformulation studies by determination of solution state degradation and lipid solubility. The compound was found to be stable in neutral and oxidative conditions and moderately stable in heated conditions.
机译:这项工作的目的是设计与脂肪酸和细胞穿透性聚L-精氨酸(polyArg)肽缀合的抗HIV核苷的缀合物。合成了三种穿透polyArg细胞的肽与阿洛夫定(FLT),拉米夫定(3TC)和恩曲他滨(FTC)的脂肪酰基衍生物的缀合物。通常,这些化合物对X4和R5无细胞病毒具有抗HIV活性,EC50值为1.5-16.6μM。 FLT-CO-(CH2)12-CO-(Arg)7对X4和R5无细胞病毒的EC50值分别为2.9μM和3.1μM。通过确定溶液状态降解和脂质溶解度,选择FLT共轭物用于进一步的预制剂研究。发现该化合物在中性和氧化条件下是稳定的,在加热条件下是中等稳定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号